Clinical trials
Stroke Patients clinical trials
Below are recruiting stroke patients clinical trials, each written for real people, not researchers. We’re tracking 422 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06885294Enrolling by invitation
Physiotherapy with hypnosis for arm recovery after stroke
This study tests whether combining physiotherapy (special exercises) with hypnosis (a focused relaxation technique) can help improve arm and hand function after a stroke. It is for people who had a stroke at least 3 months ago and still have some difficulty using one arm or hand.
LiègeAges 18–80 - NCT06793800Recruiting
Ear nerve stimulation to improve breathing after stroke
This study tests whether a gentle nerve stimulation device placed on your ear can improve your breathing after a stroke. It's for people who had a first stroke 1 to 3 years ago and are otherwise generally healthy (no heart, lung, or ear problems).
IstanbulAges 40–80 - NCT06241677Recruiting
Clot-busting therapy for stroke patients on blood thinners
This study tests whether giving a clot-busting medicine through an IV can help people who have had a stroke while taking a common blood thinner (apixaban, dabigatran, edoxaban, or rivaroxaban). It may be an option if your last dose of the blood thinner was 12 to 48 hours before the stroke and you arrive at the hospital within 4.5 hours of symptoms starting.
Hong KongAges 18 years+ - NCT05970406Enrolling by invitation
High-intensity swallow therapy after ischemic stroke
This trial tests a more intensive swallow-therapy program for people with difficulty swallowing soon after an ischemic stroke. It may help improve safety and function when eating and drinking.
Baltimore, MarylandAges 18–99 - NCT05871606RecruitingPhase 1
Breathing nitric oxide during clot-removal for stroke
This Phase 1 study tests whether inhaled nitric oxide (a gas breathed through a ventilator) can improve outcomes in people having a specific kind of emergency stroke procedure to remove a clot from the brain. It focuses on patients who need general anesthesia for the clot-removal procedure and have imaging results that suggest salvageable brain tissue.
Charlotte, North CarolinaAges 18–80 - NCT06899711Recruiting
A helmet after skull surgery to prevent sunken flap
This study tests whether wearing a custom-made external helmet after a large skull removal surgery can prevent the skin from sinking in. If you've had this surgery in the last two weeks and are being treated at a Johns Hopkins hospital, you may be eligible.
Baltimore, MarylandAges 18 years+ - NCT06633809Recruiting
Treating minor stroke with large artery blockage
This study tests whether a specific treatment (likely endovascular therapy) helps people who have a minor stroke caused by a blockage in a large brain artery. If you are eligible, you may receive this treatment within 24 hours of your stroke to try to improve your recovery.
Hangzhou, ZhejiangAges 18 years+ - NCT06715449RecruitingPhase 2/Phase 3
Testing empagliflozin after a stroke with unknown cause
This trial tests if a diabetes drug called empagliflozin can help the heart's left atrium work better in people who have had a stroke with no known cause. You may join if you are getting a heart monitor device implanted to look for hidden irregular heartbeats.
Cambridge, CambridgeshireAges 18 years+ - NCT05565781Recruiting
Watch for hidden atrial fibrillation after unexplained stroke
This study uses a smartwatch and a longer heart-monitoring test (a Holter) to find an irregular heart rhythm called atrial fibrillation after a stroke whose cause is unclear. If they detect it, it may help guide better prevention and treatment to reduce future stroke risk.
Barcelona, CataloniaAges 55 years+ - NCT04475510Recruiting
Stop blood-thinner therapy after PFO closure in younger stroke patients
This trial tests whether it’s safe to stop antithrombotic (blood-thinner) treatment after a successful hole-in-the-heart procedure (PFO closure) in people age 60 and under who had an unexplained stroke or TIA. It may help some people avoid long-term blood-thinner side effects if their risk stays low.
Québec, QuebecAges 18–60 - NCT04945174Recruiting
Stroke prevention program with exercise and education
This trial tests a structured “stroke school” program that includes supervised physical activity, education, and follow-up coaching to help reduce future stroke and heart problems. It may help people with minor stroke or a TIA who don’t need rehabilitation but do need safer ways to be more active.
Copenhagen, HerlevAges 18 years+ - NCT03821129Recruiting
Reduce recurrent stroke with a PFO closure device and antiplatelet pills
This study looks at whether closing a heart opening called a patent foramen ovale (PFO) with a special septal occluder, along with antiplatelet medications, can lower the risk of another stroke. It is for people who recently had a stroke thought to be caused by a clot that traveled from the heart but without another clear source.
Tucson, ArizonaAges 18–70 - NCT07674329Recruiting
Virtual reality rehab for arm strength after stroke
This trial tests if using virtual reality (VR) exercises early after an ischemic stroke can help improve arm muscle strength, thinking skills, and mood. It is for people who have had a stroke within the last 10 days.
TaipeiAges 18–85 - NCT07475936Recruiting
Tenecteplase for very old patients with stroke
This trial tests if a clot-busting drug called tenecteplase is safe and effective for people over 80 who have an ischemic stroke and can get treatment within 4.5 hours of symptoms starting.
Nanning, GuangxiAges 80 years+ - NCT07371624RecruitingPhase 1/Phase 2
Study of B2065 for recent ischemic stroke
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
BeijingAges 18–75 - NCT07279493RecruitingPhase 2
Testing KPCXM18 injection for acute ischemic stroke within 12 hours
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
Beijing, Beijing MunicipalityAges 18–80 - NCT06061185Recruiting
CT scans for recent hemorrhagic stroke
This study uses advanced CT scans to get a better look at bleeding in the brain (hemorrhagic stroke). It may help doctors understand the stroke and guide care.
Beijing, Beijing MunicipalityAges 18–85 - NCT06853535RecruitingPhase 3
Personalized antiplatelet therapy after stroke or TIA
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
Chengdu, SichuanAges 18 years+ - NCT07288385Recruiting
Virtual reality and brain stimulation for arm recovery after stroke
This study tests if using virtual reality along with mild brain stimulation can help improve arm and hand movement in people who have had a stroke. It is for those who are at least three months past their stroke and have moderate arm weakness.
RiyadhAges 18 years+ - NCT07448532Recruiting
Comparing electrical stimulation and mirror therapy for foot drop after stroke
This trial compares two treatments—electrical stimulation and mirror therapy—to help people who had a stroke within the last 6 months lift their foot better when walking. The goal is to improve foot clearance and reduce trips or falls.
Lahore, Punjab ProvinceAges 18–85 - NCT07381491Recruiting
Core and hip exercises for balance after stroke
This trial tests if adding special hip exercises to core strengthening can improve trunk control and balance in people who had a stroke 2 weeks to 6 months ago. It may help those who can still walk a little.
Rawalpindi, Punjab ProvinceAges 45–60 - NCT06897176RecruitingPhase 4
Cerebrolysin for speech recovery after stroke
This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.
SeoulAges 19–90 - NCT07771335Recruiting
Erlangen stroke registry: tracking strokes over time
This study collects health information from people in Erlangen, Germany who have had a stroke. It helps researchers understand stroke causes and outcomes to improve future care.
ErlangenAges 18 years+ - NCT04973579Recruiting
Stent plus heart surgery for high risk carotid patients
This trial looks at whether doing carotid artery stenting at the same time as heart surgery is safe and effective for people at high risk of stroke around the time of surgery. It targets people with significant carotid narrowing who also need heart surgery for specific heart problems.
KrakowAges 18 years+
Hear when a new Stroke Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stroke patients?
- Yes. Clin2 currently lists 422 recruiting stroke patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stroke patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stroke patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.